
|Articles|June 10, 2023
Clinical Trials at the Summit 2023: Choosing right metrics and avoiding bias in clinical trials to prevent waste
Author(s)Sheryl Stevenson
Ramin Tadayoni, MD, PhD, considers factors for choosing the right metrics and avoiding bias in clinical trials to prevent waste.
Advertisement
Ramin Tadayoni, MD, PhD, uses diabetic retinopathy as an example to illustrate choosing the right metrics and avoiding bias in clinical trials to prevent waste with Sheryl Stevenson, group editorial director, during the Clinical Trials at the Summit meeting on June 10, 2023, in Park City, Utah. Tadayoni is professor of ophthalmology, head of department, at the Université de Paris in France.
Video transcript
Editor’s note: This transcript has been edited for clarity.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retina Society 2026: MCO-010 optogenetic therapy maintains visual acuity gains through 4 years in advanced RP
2
Retina Society 2026: Medium-dose OCU410 gene therapy cuts geographic atrophy progression by up to 32% in phase 2 trial
3
Retina Society 2026: LUGANO secondary data show reduced treatment burden with vorolanib insert despite missed primary end point
4
Beyond the phenotype: Aqueous humor sampling moves retinoblastoma toward personalized therapy
5






